Stable overexpression of MEN1 suppresses tumorigenicity of RAS

被引:91
作者
Kim, YS
Burns, AL
Goldsmith, PK
Heppner, C
Park, SY
Chandrasekharappa, SC
Collins, FS
Spiegel, AM
Marx, SJ
机构
[1] NIDDK, Metab Dis Branch, Bethesda, MD 20892 USA
[2] NHGRI, Genet & Mol Biol Branch, Bethesda, MD 20892 USA
关键词
menin; MEN1; RAS; neoplasia; NIH3T3; oncogene; tumor suppressor;
D O I
10.1038/sj.onc.1203005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Although there is indirect genetic evidence that MEN1, the gene for multiple endocrine neoplasia type 1, is a tumor suppressor gene, little is known about the MEN1-encoded protein, menin. Menin was stably overexpressed in a well-characterized murine tumor cell line, (valine-12)-RAS-transformed NTH3T3 cells. Menin overexpression reverted the morphology of the RAS-transformed NIH3T3 cells towards the more flattened and more spread, fibroblastic shape of wild type NIH3T3 cells. The proliferation rate of the RAS-transformed cells in 0.5% calf serum was also slower with menin overexpression. Menin overexpression reduced the RAS-induced clonogenicity in soft agar. Menin also reduced tumor growth after injection of cells in nude mice. In conclusion, stable overexpression of MEN1 suppressed partially the RAS-mediated tumor phenotype in vitro and in vivo. Overexpressed menin protein had biological effects, directly supporting MEN1 gene function as a tumor suppressor.
引用
收藏
页码:5936 / 5942
页数:7
相关论文
共 36 条
[1]   Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription [J].
Agarwal, SK ;
Guru, SC ;
Heppner, C ;
Erdos, MR ;
Collins, RM ;
Park, SY ;
Saggar, S ;
Chandrasekharappa, SC ;
Collins, FS ;
Spiegel, AM ;
Marx, SJ ;
Burns, AL .
CELL, 1999, 96 (01) :143-152
[2]   Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states [J].
Agarwal, SK ;
Kester, MB ;
Debelenko, LV ;
Heppner, C ;
EmmertBuck, MR ;
Skarulis, MC ;
Doppman, JL ;
Kim, YS ;
Lubensky, IA ;
Zhuang, ZP ;
Green, JS ;
Guru, SC ;
Manickam, P ;
Olufemi, SE ;
Liotta, LA ;
Chandrasekharappa, SC ;
Collins, FS ;
Spiegel, AM ;
Burns, AL ;
Marx, SJ .
HUMAN MOLECULAR GENETICS, 1997, 6 (07) :1169-1175
[3]   Characterization of mutations in patients with multiple endocrine neoplasia type 1 [J].
Bassett, JHD ;
Forbes, SA ;
Pannett, AAJ ;
Lloyd, SE ;
Christie, PT ;
Wooding, C ;
Edwards, CR ;
Monson, JP ;
Sampson, J ;
Wass, JAH ;
Harding, B ;
Besser, GM ;
Wheeler, MH ;
Thakker, RV .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (02) :232-244
[4]  
Böni R, 1998, J INVEST DERMATOL, V111, P539
[5]   Positional cloning of the gene for multiple endocrine neoplasia-type 1 [J].
Chandrasekharappa, SC ;
Guru, SC ;
Manickam, P ;
Olufemi, SE ;
Collins, FS ;
EmmertBuck, MR ;
Debelenko, LV ;
Zhuang, ZP ;
Lubensky, IA ;
Liotta, LA ;
Crabtree, JS ;
Wang, YP ;
Roe, BA ;
Weisemann, J ;
Boguski, MS ;
Agarwal, SK ;
Kester, MB ;
Kim, YS ;
Heppner, C ;
Dong, QH ;
Spiegel, AM ;
Burns, AL ;
Marx, SJ .
SCIENCE, 1997, 276 (5311) :404-407
[6]  
COX DR, 1970, ANAL BINARY DATA, P14
[7]   RAS-DEPENDENT ACTIVATION OF MAP KINASE PATHWAY MEDIATED BY G-PROTEIN BETA-GAMMA-SUBUNITS [J].
CRESPO, P ;
XU, NZ ;
SIMONDS, WF ;
GUTKIND, JS .
NATURE, 1994, 369 (6479) :418-420
[8]   Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung [J].
Debelenko, LV ;
Brambilla, E ;
Agarwal, SK ;
Swalwell, JI ;
Kester, MB ;
Lubensky, IA ;
Zhuang, ZP ;
Guru, SC ;
Manickam, P ;
Olufemi, SE ;
Chandrasekharappa, SC ;
Crabtree, JS ;
Kim, YS ;
Heppner, C ;
Burns, AL ;
Spiegel, AM ;
Marx, SJ ;
Liotta, LA ;
Collins, FS ;
Travis, WD ;
EmmertBuck, MR .
HUMAN MOLECULAR GENETICS, 1997, 6 (13) :2285-2290
[9]   WILD-TYPE P53 CAN INHIBIT ONCOGENE-MEDIATED FOCUS FORMATION [J].
ELIYAHU, D ;
MICHALOVITZ, D ;
ELIYAHU, S ;
PINHASIKIMHI, O ;
OREN, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (22) :8763-8767
[10]   THE P53 PROTO-ONCOGENE CAN ACT AS A SUPPRESSOR OF TRANSFORMATION [J].
FINLAY, CA ;
HINDS, PW ;
LEVINE, AJ .
CELL, 1989, 57 (07) :1083-1093